» Articles » PMID: 16505020

Synergistic Effect of Platelet-activating Factor and Tumor Necrosis Factor-alpha on Corneal Myofibroblast Apoptosis

Overview
Specialty Ophthalmology
Date 2006 Mar 1
PMID 16505020
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Elimination of myofibroblasts after repair of corneal injury is essential for the maintenance of corneal transparency. In the current study, the role of platelet-activating factor (PAF) in combination with tumor necrosis factor (TNF)-alpha in corneal myofibroblast apoptosis was explored.

Methods: Porcine corneal myofibroblasts (PCMs) were obtained from subcultured fibroblasts plated at a low density (5 cells/mm2). Mouse anti-alpha-smooth muscle actin antibody was used to identify the cell phenotype. Immunofluorescence was performed to localize PAF and TNF-alpha receptors in those cells. The reactivity of the antibodies was characterized by Western blot analysis. To induce myofibroblast apoptosis, PCMs were treated for 24 to 72 hours with methylcarbamyl-PAF (cPAF, 300 nM), a nonhydrolyzable PAF analogue, TNF-alpha (20 ng/mL), and TNF-alpha+cPAF, with or without LAU-0901 (150 nM), a novel PAF antagonist. Apoptosis was assayed by Hoechst 33258 and TUNEL staining and DNA laddering. 6-Diamidino-2-phenylindole (DAPI) was used for nuclear counterstaining. Images were recorded by fluorescence microscope.

Results: Immunofluorescence with a PAF-receptor (N terminus) polyclonal antibody showed that the receptor was expressed in both plasma and nuclear membranes of myofibroblasts. TNF-alpha receptor II (TNF-RII) was localized in the cytoplasm, whereas TNF-receptor I (TNF-RI) was found in both cytoplasm and plasma membrane. Treatment with TNF-alpha for 24, 48, and 72 hours induced apoptosis in 18%, 24%, and 32%, respectively, of the myofibroblasts. Western blot analysis showed expression of single bands corresponding to the molecular weights of the receptors. Treatment with cPAF induced apoptosis in 10%, 18%, and 26% of the cells, respectively. However, treatment with both cytokines induced apoptosis in 42%, 78%, and 86%, respectively, of the cells, demonstrating a synergistic action between PAF and TNF-alpha. Blocking the PAF receptor with LAU-0901 inhibited the synergistic effect induced by PAF.

Conclusions: Corneal myofibroblasts express a PAF receptor in the nuclear membrane, and they also express TNF-RI and RII. The synergistic effect on myofibroblast apoptosis by PAF and TNF-alpha suggests that during corneal stromal wound healing, PAF acting in conjunction with other cytokines could play an important role in eliminating these cells.

Citing Articles

Combined Therapy With Avastin, a PAF Receptor Antagonist and a Lipid Mediator Inhibited Glioblastoma Tumor Growth.

Cruz Flores V, Menghani H, Mukherjee P, Marrero L, Obenaus A, Dang Q Front Pharmacol. 2021; 12:746470.

PMID: 34630114 PMC: 8498947. DOI: 10.3389/fphar.2021.746470.


Multiprong control of glioblastoma multiforme invasiveness: blockade of pro-inflammatory signaling, anti-angiogenesis, and homeostasis restoration.

Bazan N, Reid M, Cruz Flores V, Gallo J, Lewis W, Belayev L Cancer Metastasis Rev. 2021; 40(3):643-647.

PMID: 34519960 PMC: 8556176. DOI: 10.1007/s10555-021-09987-x.


Corneal stromal wound healing: Major regulators and therapeutic targets.

Kamil S, Mohan R Ocul Surf. 2020; 19:290-306.

PMID: 33127599 PMC: 9183221. DOI: 10.1016/j.jtos.2020.10.006.


TMF and glycitin act synergistically on keratinocytes and fibroblasts to promote wound healing and anti-scarring activity.

Seo G, Lim Y, Koh D, Huh J, Hyun C, Kim Y Exp Mol Med. 2017; 49(3):e302.

PMID: 28303029 PMC: 5382558. DOI: 10.1038/emm.2016.167.


Expressions of tumor necrosis factor-α, its receptor I, II and receptor-associated factor 2 in the porcine corpus luteum during the estrous cycle and early pregnancy.

Suzuki C, Yoshioka K, Yamada M, Miyamoto T, Manabe N Vet Res Commun. 2013; 38(1):1-10.

PMID: 24057858 DOI: 10.1007/s11259-013-9575-9.